138 related articles for article (PubMed ID: 37004278)
1. Clinicopathological and prognostic value of lncRNA TPT1-AS1 in cancer: A systematic review study and meta-analysis.
Rastad H; Mozafary Bazargany MH; Samimisedeh P; Farahani M; Hashemnejad M; Moghadam S; Khodaparast Z; Shams R; Seifi-Alan M
Pathol Res Pract; 2023 May; 245():154403. PubMed ID: 37004278
[TBL] [Abstract][Full Text] [Related]
2. The role of lncRNA CERS6-AS1 in cancer and its molecular mechanisms: A systematic review and meta-analysis.
Rastad H; Samimisedeh P; Alan MS; Afshar EJ; Ghalami J; Hashemnejad M; Alan MS
Pathol Res Pract; 2023 Jan; 241():154245. PubMed ID: 36580796
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
Zhong P; Hua H; Chen S; Zhu Z; Xie F
Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X
Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821
[TBL] [Abstract][Full Text] [Related]
5. Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer.
Hu C; Fang K; Zhang X; Guo Z; Li L
Pathol Res Pract; 2020 Nov; 216(11):153216. PubMed ID: 32961484
[TBL] [Abstract][Full Text] [Related]
6. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
Shu Q; Liu X; Yang J; Mou T; Xie F
Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
[TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
Zhang C; Ren X; Liu Z; Tu C
BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
[TBL] [Abstract][Full Text] [Related]
8. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer.
Cheng C; Liu D; Liu Z; Li M; Wang Y; Sun B; Kong R; Chen H; Wang G; Li L; Hu J; Li Y; Chen H; Zhao Z; Zhang T; Zhu S; Pan S
Cancer Sci; 2022 Sep; 113(9):2986-3001. PubMed ID: 35534983
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L; Liu QM; Zhang S; Zhou J
Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
Wang X; Chen Z; Zhou H; Liu W; Luo J
Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of high LncRNA AFAP1-AS1 expression in various cancers: A systematic review and meta-analysis containing 21 studies.
Zhou Y; Chen S; Cheng S; Wei Q; Fathy AH; Shan T
Clin Chim Acta; 2018 Jun; 481():147-153. PubMed ID: 29544748
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
Chen C; Feng Y; Wang X
Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
Zhou X; Fan YH; Wang Y; Wang F; Liu Y
Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Wang J; Zhong P; Hua H
Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA TPT1-AS1 promotes angiogenesis and metastasis of colorectal cancer through TPT1-AS1/NF90/VEGFA signaling pathway.
Zhang Y; Sun J; Qi Y; Wang Y; Ding Y; Wang K; Zhou Q; Wang J; Ma F; Zhang J; Guo B
Aging (Albany NY); 2020 Apr; 12(7):6191-6205. PubMed ID: 32248186
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2.
Wei W; Huang X; Shen X; Lian J; Chen Y; Wang W; Huang J; Zhang B
Crit Rev Eukaryot Gene Expr; 2022; 32(1):1-9. PubMed ID: 35377976
[TBL] [Abstract][Full Text] [Related]
19. High expression of long noncoding RNA LUCAT1 correlates with a poor clinical outcome in solid tumors: A systematic review and meta-analysis.
Lv P; Ye T; Yang X; Liu H; Ye Z
Pathol Res Pract; 2020 Sep; 216(9):153047. PubMed ID: 32825932
[TBL] [Abstract][Full Text] [Related]
20. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]